Experiment 1115136
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | KELSEN,D: GRALLA,R: CHENG,E: MARTINI,N:. (1983). VINDESINE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA: A PHASE II STUDY.. 67(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE II TRIAL OF VINDESINE WAS PERFORMED IN PATIENTS WITH ADVANCED MALIGNANT MESOTHELIOMA. THE DRUG WAS GIVEN AT A DOSE OF 3 MG/SQ M ONCE WEEKLY FOR 4-6 WEEKS AND THEN EVERY 2 WEEKS THEREAFTER. ONLY ONE OF 17 EVALUABLE PATIENTS HAD A PARTIAL REMISSION,LASTING 5 MONTHS. TOXIC EFFECTS INCLUDED LEUKOPENIA,PERIPHERAL NEUROPATHY AND ALOPECIA. IT WAS CONCLUDED THAT VINDESINE HAS MINIMAL ACTIVITY IN MALIGNANT MESOTHELIOMA. |
| Dose amount | 3.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |